Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Estetra
- Target Recruit Count
- 76
- Registration Number
- NCT06308614
- Locations
- ๐บ๐ธ
Estetra Study Site, Houston, Texas, United States
Effect of Estetrol Monohydrate (E4) on QTc Interval
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Estetra
- Target Recruit Count
- 32
- Registration Number
- NCT04819906
- Locations
- ๐บ๐ธ
QPS Miami, Miami, Florida, United States
Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents
- First Posted Date
- 2021-03-11
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Estetra
- Target Recruit Count
- 145
- Registration Number
- NCT04792385
- Locations
- ๐ช๐ช
KVL Medical Office/KVL Arstikabinet, Parnu, Estonia
๐ช๐ชSexual Health Clinic, Tallinn, Tallinn, Estonia
๐ช๐ชSexual Health Clinic, Tartu, Tartu, Estonia
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-12-24
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Estetra
- Target Recruit Count
- 1570
- Registration Number
- NCT04209543
- Locations
- ๐ฌ๐ง
Estetra Study Site, Orpington, United Kingdom
๐บ๐ธNoble Clinical Research, Tucson, Arizona, United States
๐บ๐ธInfinite Clinical Trials, Morrow, Georgia, United States
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Estetra
- Target Recruit Count
- 1015
- Registration Number
- NCT04090957
- Locations
- ๐จ๐ฆ
Estetra Study Site, Waterloo, Canada
Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study
- First Posted Date
- 2018-05-01
- Last Posted Date
- 2018-12-14
- Lead Sponsor
- Estetra
- Target Recruit Count
- 24
- Registration Number
- NCT03512860
- Locations
- ๐ฌ๐ง
Quotient Sciences, Ruddington, Nottingham, United Kingdom
E4/DRSP Ovarian Function Inhibition Study
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Estetra
- Target Recruit Count
- 82
- Registration Number
- NCT03091595
- Locations
- ๐ณ๐ฑ
Dinox BV, Groningen, Netherlands
Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-03-09
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- Estetra
- Target Recruit Count
- 31
- Registration Number
- NCT03075956
- Locations
- ๐ง๐ฌ
COMAC, Sofia, Bulgaria
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Estetra
- Target Recruit Count
- 101
- Registration Number
- NCT02957630
- Locations
- ๐ณ๐ฑ
Dinox BV, Groningen, Netherlands
E4/DRSP Single and Multiple Dose PK and Early QT Study
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Estetra
- Target Recruit Count
- 55
- Registration Number
- NCT02874248
ยฉ Copyright 2024. All Rights Reserved by MedPath